Enzyme-mediated drug-drug interactions: a review of <i>in vivo</i> and <i>in vitro</i> methodologies, regulatory guidance, and translation to the clinic-Reference-Cited by-同舟云学术

Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic

Published:2024-07-26 Issue: Volume: Page:1-33
ISSN:0360-2532
Container-title:Drug Metabolism Reviews
language:en
Short-container-title:Drug Metabolism Reviews

Author:

Yadav Jaydeep¹^ORCID,Maldonato Benjamin J.²^ORCID,Roesner Joseph M.¹,Vergara Ana G.³^ORCID,Paragas Erickson M.⁴^ORCID,Aliwarga Theresa⁴^ORCID,Humphreys Sara⁴^ORCID

Affiliation:

1. Department of Pharmacokinetics, Dynamics, Metabolism & Bioanalytics (PDMB), Merck & Co., Inc., Boston, MA, USA

2. Department of Nonclinical Development and Clinical Pharmacology, Revolution Medicines, Inc., Redwood City, CA, USA

3. Department of Pharmacokinetics, Dynamics, Metabolism & Bioanalytics (PDMB), Merck & Co., Inc., Rahway, NJ, USA

4. Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, CA, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03602532.2024.2381021

Reference232 articles.

1. Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends

2. Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic Model

3. AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS

4. Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studies

5. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin